Literature DB >> 15204741

Biochemical and behavioral effects of soman vapors in low concentrations.

Jiri Bajgar1, Lucie Sevelová, Gabriela Krejcová, Josef Fusek, Josef Vachek, Jiri Kassa, Josef Herink, Leo P A de Jong, Hendrik P Benschop.   

Abstract

Soman belongs to the most dangerous nerve agents because of the low effectiveness of the presently available antidotes. Soman acts by inhibiting acetylcholinesterase (AChE) both peripherally and centrally, with a subsequent accumulation of neuromediator acetylcholine and other metabolic changes. From the data published in literature it can be concluded that exposure to nerve agents leading to acute effects or chronic exposure to nerve agents may lead to delayed and persistent adverse effects. The aim of this study was to demonstrate changes in AChE and butyrylcholinesterase (BuChE) activities, stressogenic markers (i.e., tyrosine aminotransferase [TAT] activity, and plasma corticosterone level), and neuroexcitability and behavior 24 h and 4 wk following a single soman inhalation exposure at low level. AChE activity in erythrocytes and BuChE activity in plasma was decreased (dependent on the dose of soman) 24 h and 4 wk after the exposure. A similar decrease in AChE activity in different brain parts was observed. One of the stressogenic parameters, TAT, was changed 24 h after exposure only. Behavior of experimental animals was changed 24 h after the exposure, and 4 behavioral parameters persisted 4 wk after the exposure. Neuroexcitability was increased at 24 h after the exposure and had become about normal 4 wk after the exposure. Summarizing, long-term effects (4 wk) were observed after inhalation exposure of guinea pigs to sublethal concentrations of soman.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15204741     DOI: 10.1080/08958370490442430

Source DB:  PubMed          Journal:  Inhal Toxicol        ISSN: 0895-8378            Impact factor:   2.724


  9 in total

1.  Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology.

Authors:  James P Apland; Taiza H Figueiredo; Felicia Qashu; Vassiliki Aroniadou-Anderjaska; Adriana P Souza; Maria F M Braga
Journal:  Neurotoxicology       Date:  2010-06-08       Impact factor: 4.294

2.  Animal models that best reproduce the clinical manifestations of human intoxication with organophosphorus compounds.

Authors:  Edna F R Pereira; Yasco Aracava; Louis J DeTolla; E Jeffrey Beecham; G William Basinger; Edgar J Wakayama; Edson X Albuquerque
Journal:  J Pharmacol Exp Ther       Date:  2014-06-06       Impact factor: 4.030

3.  Primary brain targets of nerve agents: the role of the amygdala in comparison to the hippocampus.

Authors:  Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; James P Apland; Felicia Qashu; Maria F M Braga
Journal:  Neurotoxicology       Date:  2009-07-08       Impact factor: 4.294

4.  Soman induces ictogenesis in the amygdala and interictal activity in the hippocampus that are blocked by a GluR5 kainate receptor antagonist in vitro.

Authors:  J P Apland; V Aroniadou-Anderjaska; M F M Braga
Journal:  Neuroscience       Date:  2008-12-14       Impact factor: 3.590

5.  Transcriptional responses of the nerve agent-sensitive brain regions amygdala, hippocampus, piriform cortex, septum, and thalamus following exposure to the organophosphonate anticholinesterase sarin.

Authors:  Kimberly D Spradling; Lucille A Lumley; Christopher L Robison; James L Meyerhoff; James F Dillman
Journal:  J Neuroinflammation       Date:  2011-07-21       Impact factor: 8.322

6.  Transcriptional analysis of rat piriform cortex following exposure to the organophosphonate anticholinesterase sarin and induction of seizures.

Authors:  Kimberly D Spradling; Lucille A Lumley; Christopher L Robison; James L Meyerhoff; James F Dillman
Journal:  J Neuroinflammation       Date:  2011-07-21       Impact factor: 8.322

7.  (-)-Phenserine attenuates soman-induced neuropathology.

Authors:  Jun Chen; Hongna Pan; Cynthia Chen; Wei Wu; Kevin Iskandar; Jeffrey He; Tetsade Piermartiri; David M Jacobowitz; Qian-Sheng Yu; John H McDonough; Nigel H Greig; Ann M Marini
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

8.  Three-dimensional (3D) tetra-culture brain on chip platform for organophosphate toxicity screening.

Authors:  Youngmi Koo; Brian T Hawkins; Yeoheung Yun
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

9.  Three-dimensional brain-on-chip model using human iPSC-derived GABAergic neurons and astrocytes: Butyrylcholinesterase post-treatment for acute malathion exposure.

Authors:  Lumei Liu; Youngmi Koo; Teal Russell; Elaine Gay; Yan Li; Yeoheung Yun
Journal:  PLoS One       Date:  2020-03-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.